DOI: https://doi.org/10.18370/2309-4117.2019.49.43-49

Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods

І. А. Жабченко, О. Р. Сюдмак

Abstract


To date, there has been a significant shift in the age structure of pregnant women in developed countries towards an increasing the proportion of older reproductive women (over 35 years). First of all, it is caused by social trends and successes in the development of reproductive medicine, which has both positive and negative consequences.

35+ women are at increased risk of blood pressure and diabetes, first discovered during pregnancy; the risk of having a baby with chromosomal abnormalities increases with age (the most common is Down syndrome); increases the frequency of miscarriages, ectopic pregnancy, placental presentation, stillbirths, births of children with low body weight and asphyxia, delivery by caesarean section.

The article presents up-to-date data on the features of the ovarian reserve, menstrual function and pregnancy onset in late reproductive women. The main risk factors that can prevent the onset of the desired pregnancy in this contingent of women and its normal course, and can cause early reproductive losses are described. The role of nutritional deficits, psychological and physical stressors, infectious component, abortive history, surgical interventions and chronic endometritis that are causes of infertility in women aged 35+ were determined.

Given the identified risk factors the main directions of infertility causes correction and principles of pregravid preparation in women with reproductive disorders, which are recommended to be implemented in conjunction with specialized specialists (family doctor, endocrinologist, cardiologist, and neurologist) are identified. Among the main measures at the pregravid stage is correction of hormonal relations in a woman's body and endometrium state (normalization of the menstrual cycle with provision of its two-phase, correction of luteal phase insufficiency for ovulation), treatment of chronic endometritis, folate supplementation with taking into account hypoproteremia, weight loss, correction of hypertensive disorders, psychological support for married couples

Keywords


delayed childbearing; late reproductive age; infertility; hormonal imbalance; obesity; pregravid preparation

References


Bulavenko, O.V., Dzis, N.P., Furman, O.V. “Treatment of endometrial hyperplastic processes in women of late reproductive age with overweight.” Reproductive health. Eastern Europe 3.39 (2015): 121–7.

Bulavenko, O.V. “Modern look of the obstetrician-gynecologist at the multivariate complex for children.” Reproductive Endocrinology 3.47 (2019): 64–6.

Gromova, O.A., Torshin, I.Y., Tetruashvili, N.K., Lisitsyna, E.Y. “A systematic analysis of the relationship between vitamin deficiency and congenital malformations.” Consilium Medicum Vol. 6 (2012): 34–40.

Gromova, O.A., Torshin, I.Y., Limanova, O.A. “Prospects for the use of myo-inositol in women with polycystic ovary and insulin resistance in programs of pregravid preparation for in vitro fertilization.” Effective Pharmacotherapy. Obstetrics and gynecology 5.51 (2013).

Dankovich, N.O., Babenko, O.M. “Therapeutic Possibilities of Preparing Women with Infertility for IVF.” Reproductive Endocrinology 2.34 (2017).

Zhabchenko, I.A. “Contemporary view on the role of folates in the prevention of perinatal problems.” Reproductive endocrinology 2.46 (2019): 57–61.

Kalugina, L.V., Yusko, T.I. “Myo-inositol: Therapeutic possibilities and pregravid preparation for polycystic ovary syndrome.” Reproductive endocrinology 4.42 (2018): 40–5.

Silina, N.K., Koval, G.M., Silina, T.N., et al. “Deficiency states in women during pregravid preparation for pregnancy and their correction. Review of International Studies.” A word about health 19 (2019). Obstetrics. Available from: [https://ozdorovvvvie.com.ua/category/rozdili/akusherstvo-uk].

Croce, M.L., Sulage, S.O. “The potential role and therapeutic interest of myo-inositol in metabolic diseases.” Biochimie 95.10 (2013): 1811.

Mashina, M.A. Optimization of specialized care for a barren couple. Thesis for PhD degree. Moscow (2015): 172 p.

Kaminskyi, V.V., Tatarchuk, T.F., et al. “National Consensus on the management of patients with hyperandrogenism.” Reproductive endocrinology 4.30 (2016): 19–31.

Radzinsky, V.E., ed. Ovarian reserve and fertility: difficulties of the 21st century. Information letter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.

Podzolkova, N.M., Nazarova, S.V., Chizhova, M.A., Prilepina, I.A. “Pregnancy, luing-ins and perinatal ends for the women of late reproductive age.” Farmateka 3 (2016): 62–7.

Radzinsky, V.E., et al. Pregravid preparation: clinical protocol. Moscow. Editorial board of StatusPraesens journal (2016): 80 p.

Pustotina, O.A., Akhmedova, A.E. “The role of folates in the development of pregnancy complications.” Women's Health 1.117 (2017): 56–61.

Radzinsky, V.E., Ryabinkina, T.S., Raevskaya, O.A. “Technogenic selection.” StatusPraesens 5.42.11 (2017): 103–10.

Bevilakua, A., Carlomanjo, J., Gerley, S., et al. “Results of an international consensus conference on the use of myo-inositol and D-chiro-inositol in obstetrics and gynecology and, in particular, in IVF.” A word about health 19 (2019). Obstetrics. Available from: [https://ozdorovvvvie.com.ua/category/rozdili/akusherstvo-uk].

World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva. WHO (2017).

Shestakova, I.G., Ryabinkina, T.S.; ed. by V.E. Radzinsky. PCOS: a new look at the problem. Variety of symptoms, differential diagnosis and treatment of PCOS. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.

Ryabinkina, T.S., Simonovskaya, H.Y., Rudnev, O.D.; ed. by V.E. Radzinsky. Older reproductive age: contraception and more. Rational contraception of older women: contraceptive and non-contraceptive aspects. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2014): 16 p.

Tatarchuk, T.F., Ganzhyi, I.Y., Pedachenko, N.Y., Kapshuk, I.M. “Current possibilities of non-hormonal treatment of polycystic ovary syndrome in women with obesity.” Reproductive endocrinology 5.13 (2013): 19–21.

Shatkovska, A.S., Shimanska, O.G. “Hormonal contraception in women of late reproductive age.” Medical aspects of women's health 8.37 (2010): 35–40.

Khamoshina, M.B., Lebedeva, M.G., Simonovskaya, H.Y.; ed. by V.E. Radzinsky. Ecological and reproductive dissonance of the XXI century: to prevent negative consequences. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.

Ismail, A.M., Hamed, A.H., Saso, S., Thabet, H.H. “Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate.” Eur J Obstet Gynecol Reprod Biol 180 (2014): 148–52.

Fauser, B.C.J.M., et al. “Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.” Fertil Steril 97.1 (2012): 28–38.e25.

D’Anna, R., Di Benedetto, V., Rizzo, P., et al. “Myo-inositol may prevent gestational diabetes in PCOS women.” Gynecol Endocrinol 28.6 (2012): 440–2.

Papaleo, E., Unfer, V., Baillargeon, J.P., et al. “Contribution of myo-inositol to reproduction.” Eur J Obstet Gynecol Reprod Biol 147.2 (2009):120–3.

Unfer, V., Carlomagno, G., Dante, G., et al. “Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.” Gynecol Endocrinol 28.7 (2012): 509–15.

Eltbogen, R., et al. “Vitex-agnus-castus-Extrakt (Ze 440) zur Symptom-behandlung bei Frauen mit menstruellen Zyklusstörungen.” Journal fur Gynakologische Endokrinologie 25.2 (2015): 10–5.

Thomson, R.L., Buckley, J.D., Brinkworth, G.D. “Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.” Obes Rev 12 (2011): 202–10.

Genazzani, A.D., Prati, A., Santagni, S., et al. “Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.” Gynecol Endocrinol 28.12 (2012): 969–73.

Unfer, V., Carlomagno, G., Rizzo P., et al. “Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Eur Rev Med harmacol Sci 15.4 (2011): 452–7.

Carlomagno, G., De Grazia, S., Unfer, V. “Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use.” Expert Opin Drug Deliv 9.3 (2012): 267–71.

Рapaleo, T., Unfer, V., Baillargeon, J.R., et al. “Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Fertil Steril 91 (2009): 1750–4.

Pietrzik, K., еt al. “Folic Acid and L-5-Methyltetrahydrofolate Compression of clinical pharmacokinetics and pharmacodynamics.” Clin Pharmacokinetic 49 (2010): 8.

Jahre, A., Dietl, S., Cupisti, M., et al. “Schwangerschaft und Geburt bei Frauen über 40.” Zollner Geburtshilfe Frauenheilkd 75.08 (2015): 827–32.

Raffone, E., Rizzo, P., Benedetto, V. “Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.” Gynecol Endocrinol 26.8 (2010): 275–80.

Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus.” Biochem Pharmacol 81.1 (2011): 170–7.

Artini, P.G., Di Berardino, O.M., Papini F., et al. “Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.” Gynecol Endocrinol 29.4 (2013): 375–9.

Ciotta, L., Stracquadanio, M., Pagano, I., et al. “Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial.” Eur Rev Med Pharmacol Sci 15.5 (2011): 509–14.

Schellenberg, R., Zimmermann, C., Drewe, J., et al. “Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome: multicenter, double-blind, placebo-controlled, randomized, prospective trial.” Phytomedicine 19.14 (2012): 1325–31.


GOST Style Citations


1. Булавенко, О.В. Лечение гиперпластических процессов эндометрия у женщин позднего репродуктивного возраста с избыточным весом / О.В. Булавенко, Н.П. Дзись, О.В. Фурман // Репродуктивное здоровье. Восточная Европа. – 2015. – № 3 (39). – С. 121–127.

2.         Булавенко, О.В. Сучасний погляд акушера-гінеколога на полівітамінні комплекси для вагітних / О.В. Булавенко // Репродуктивна ендокринологія. – 2019. – № 3 (47). – С. 64–66.

3.         Громова, О.А. Систематический анализ взаимосвязи дефицита витаминов и врожденных пороков развития / О.А. Громова, И.Ю. Торшин, Н.К. Тетруашвили,

Е.Ю. Лисицына // Consilium Medicum. – 2012. – T. 6. – C. 34–40.

4.         Громова, О.А. Перспективы использования мио-инозитола у женщин с поликистозом яичников и инсулинорезистентностью в программах прегравидарной подготовки к экстракорпоральному оплодотворению / О.А. Громова, И.Ю. Торшин, О.А. Лиманова // Эффективная фармакотерапия. Акушерство и гинекология. – 2013. – № 5 (51).

5.         Данкович, Н.О. Терапевтичні можливості підготовки жінок із безпліддям до ЕКЗ / Н.О. Данкович, О.М. Бабенко // Репродуктивна ендокринологія. – 2017. – №2 (34).

6.         Жабченко, І.А. Сучасний погляд на роль фолатів у профілактиці перинатальних проблем / І.А. Жабченко // Репродуктивна ендокринологія. – 2019. – № 2 (46). – С. 57–61.

7.         Калугина, Л.В. Мио-инозитол: Терапевтические возможности и прегравидарная подготовка при синдроме поликистозных яичников / Л.В. Калугина, Т.И. Юско // Репродуктивная эндокринология. – 2018. – № 4 (42). – С. 40–45.

8.         Сіліна, Н.К. Дефіцитні стани в жінок під час прегравідарної підготовки до вагітності і їх корекція. Огляд міжнародних досліджень / Н.К. Сіліна, Г.М. Коваль, Т.Н. Сіліна та ін. // Слово про здоров’я. – 2019. – Випуск 19. Акушерство.

9.         Кроче, М.Л. Потенциальная роль и терапевтический интерес мио-инозитола при метаболических заболеваниях / М.Л. Кроче, С.О. Сулаж // Biochimie. – 2013. – Т. 95, № 10. – С. 1811.

10.       Машина, М.А. Оптимизация специализированной медицинской помощи бесплодной паре : дисс. … канд. мед. наук. – М., 2015. – 172 с.

11.       Камінський, В.В. Національний Консенсус щодо ведення пацієнток із гіперандрогенією / В.В. Камінський, Т.Ф. Татарчук та ін. // Репродуктивна ендокринологія. – 2016. – № 4 (30). – С. 19–31.

12.       В.Е. Радзинский, ред. Овариальный резерв и фертильность: сложности ХХІ века. Инф. письмо / Под ред. В.Е. Радзинского. – М.: Редакция журнала StatusPraesens, 2015. – 24 c.

13.       Подзолкова, Н.М. Беременность, роды и перинатальные исходы у женщин позднего репродуктивного возраста / Н.М. Подзолкова, С.В. Назарова, М.А. Чижова, И.А. Прилепина // Фарматека. – 2016. – № 3. – С. 62–67.

14.       Радзинский, В.Е. Прегравидарная подготовка: клинический протокол / В.Е. Радзинский и др. – М.: Редакция журнала StatusPraesens, 2016. – 80 с.

15.       Пустотина, О.А. Роль фолатов в развитии осложнений беременности / О.А. Пустотина, А.Э. Ахмедова // Здоровье женщины. – 2017. – № 1 (117). – С. 56–61.

16.       Радзинский, В.Е. Техногенный отбор / В.Е. Радзинский, Т.С. Рябинкина,

О.А. Раевская // StatusPraesens. – 2017. – № 5 (42), 11. – С. 103–110.

17.       Бевілакуа, А. Результати міжнародної консенсусної конференції із застосування міо-інозитолу та Д-хіро-інозитолу в акушерстві й гінекології й, зокрема, у ДРТ / А. Бевілакуа, Дж. Карломаньйо, С. Герлі та ін. // Слово про здоров’я. – 2019. – Випуск 19. Акушерство.

18.       Всемирная организация здравоохранения. Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности. – Женева: ВОЗ, 2017.

19.       Шестакова, И.Г. СПКЯ: новый взгляд на проблему. Многообразие симптомов, дифференциальная диагностика и лечение СПКЯ. Информационный бюллетень / И.Г. Шестакова, Т.С. Рябинкина; под ред. В.Е. Радзинского. – М.: Редакция журнала StatusPraesens, 2015. – 24 с.

20.       Рябинкина, Т.С. Старший репродуктивный возраст: контрацепция и не только. Рациональная контрацепция женщин старшего возраста: контрацептивные и неконтрацептивные аспекты. Информационный бюллетень / Т.С. Рябинкина, Х.Ю. Симоновская, О.Д. Руднева; под ред. В.Е. Радзинского. – М.: Редакция журнала StatusPraesens, 2014. – 16 с.

21.       Татарчук, Т.Ф. Сучасні можливості негормонального лікування синдрому полікістозних яєчників у жінок з ожирінням / Т.Ф. Татарчук, І.Ю. Ганжий, Н.Ю. Педаченко, І.М. Капшук // Репродуктивна ендокринологія. – 2013. – № 5 (13). – С.19–21.

22.       Шатковська, А.С. Гормональна контрацепція у жінок пізнього репродуктивного віку / А.С. Шатковська, О.Г. Шиманська // Медичні аспекти здоров’я жінки. – 2010. – № 8 (37). – С. 35–40.

23.       Хамошина, М.Б. Эколого-репродуктивный диссонанс ХХІ века: предупредить негативные последствия. Информационный бюллетень / М.Б. Хамошина, М.Г. Лебедева, Х.Ю. Симоновская; под ред. В.Е. Радзинского. – М.: Редакция журнала StatusPraesens, 2015. – 24 с.

24. Ismail, A.M., Hamed, A.H., Saso, S., Thabet, H.H. “Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate.” Eur J Obstet Gynecol Reprod Biol 180 (2014): 148–52.

25.       Fauser, B.C.J.M., et al. “Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.” Fertil Steril 97.1 (2012): 28–38.e25.

26.       D’Anna, R., Di Benedetto, V., Rizzo, P., et al. “Myo-inositol may prevent gestational diabetes in PCOS women.” Gynecol Endocrinol 28.6 (2012): 440–2.

27.       Papaleo, E., Unfer, V., Baillargeon, J.P., et al. “Contribution of myo-inositol to reproduction.” Eur J Obstet Gynecol Reprod Biol 147.2 (2009):120–3.

28.       Unfer, V., Carlomagno, G., Dante, G., et al. “Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.” Gynecol Endocrinol 28.7 (2012): 509–15.

29.       Eltbogen, R., et al. “Vitex-agnus-castus-Extrakt (Ze 440) zur Symptom-behandlung bei Frauen mit menstruellen Zyklusstörungen.” Journal fur Gynakologische Endokrinologie 25.2 (2015): 10–5.

30.       Thomson, R.L., Buckley, J.D., Brinkworth, G.D. “Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.” Obes Rev 12 (2011): 202–10.

31.       Genazzani, A.D., Prati, A., Santagni, S., et al. “Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.” Gynecol Endocrinol 28.12 (2012): 969–73.

32.       Unfer, V., Carlomagno, G., Rizzo P., et al. “Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Eur Rev Med harmacol Sci 15.4 (2011): 452–7.

33.       Carlomagno, G., De Grazia, S., Unfer, V. “Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use.” Expert Opin Drug Deliv 9.3 (2012): 267–71.

34.       Рapaleo, T., Unfer, V., Baillargeon, J.R., et al. “Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Fertil Steril 91 (2009): 1750–4.

35.       Pietrzik, K., еt al. “Folic Acid and L-5-Methyltetrahydrofolate Compression of clinical pharmacokinetics and pharmacodynamics.” Clin Pharmacokinetic 49 (2010): 8.

36.       Jahre, A., Dietl, S., Cupisti, M., et al. “Schwangerschaft und Geburt bei Frauen über 40.” Zollner Geburtshilfe Frauenheilkd 75.08 (2015): 827–32.

37.       Raffone, E., Rizzo, P., Benedetto, V. “Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.” Gynecol Endocrinol 26.8 (2010): 275–80.

38.       Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus.” Biochem Pharmacol 81.1 (2011): 170–7.

39.       Artini, P.G., Di Berardino, O.M., Papini F., et al. “Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.” Gynecol Endocrinol 29.4 (2013): 375–9.

40.       Ciotta, L., Stracquadanio, M., Pagano, I., et al. “Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial.” Eur Rev Med Pharmacol Sci 15.5 (2011): 509–14.

41.       Schellenberg, R., Zimmermann, C., Drewe, J., et al. “Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome: multicenter, double-blind, placebo-controlled, randomized, prospective trial.” Phytomedicine 19.14 (2012): 1325–31.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)